<VariationArchive VariationID="2952341" VariationName="NM_000044.6(AR):c.1844del (p.Cys615fs)" VariationType="Deletion" Accession="VCV002952341" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3112019" VariationID="2952341">
      <GeneList>
        <Gene Symbol="AR" FullName="androgen receptor" GeneID="367" HGNC_ID="HGNC:644" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="67544021" stop="67730619" display_start="67544021" display_stop="67730619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="66763873" stop="66950460" display_start="66763873" display_stop="66950460" Strand="+" />
          </Location>
          <OMIM>313700</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AR">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AR">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000044.6(AR):c.1844del (p.Cys615fs)</Name>
      <CanonicalSPDI>NC_000023.11:67686084:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="67686085" stop="67686085" display_start="67686085" display_stop="67686085" variantLength="1" positionVCF="67686084" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="66905927" stop="66905927" display_start="66905927" display_stop="66905927" variantLength="1" positionVCF="66905926" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>C83fs</ProteinChange>
      <ProteinChange>C615fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.66905927del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.66905927del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.67686085del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.67686085del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009014.2" sequenceAccession="NG_009014" sequenceVersion="2" change="g.147054del">
            <Expression>NG_009014.2:g.147054del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000044.6" sequenceAccession="NM_000044" sequenceVersion="6" change="c.1844del" MANESelect="true">
            <Expression>NM_000044.6:c.1844del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000035.2" sequenceAccession="NP_000035" sequenceVersion="2" change="p.Cys615fs">
            <Expression>NP_000035.2:p.Cys615fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001011645.3" sequenceAccession="NM_001011645" sequenceVersion="3" change="c.248del">
            <Expression>NM_001011645.3:c.248del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001011645.1" sequenceAccession="NP_001011645" sequenceVersion="1" change="p.Cys83fs">
            <Expression>NP_001011645.1:p.Cys83fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348061.1" sequenceAccession="NM_001348061" sequenceVersion="1" change="c.1844del">
            <Expression>NM_001348061.1:c.1844del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334990.1" sequenceAccession="NP_001334990" sequenceVersion="1" change="p.Cys615fs">
            <Expression>NP_001334990.1:p.Cys615fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348063.1" sequenceAccession="NM_001348063" sequenceVersion="1" change="c.1844del">
            <Expression>NM_001348063.1:c.1844del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001334992.1" sequenceAccession="NP_001334992" sequenceVersion="1" change="p.Cys615fs">
            <Expression>NP_001334992.1:p.Cys615fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001348064.1" sequenceAccession="NM_001348064" sequenceVersion="1" change="c.*42del">
            <Expression>NM_001348064.1:c.*42del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001424175.1" sequenceAccession="NM_001424175" sequenceVersion="1" change="c.1847delG">
            <Expression>NM_001424175.1:c.1847delG</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001411104.1" sequenceAccession="NP_001411104" sequenceVersion="1" change="p.Cys616Phefs">
            <Expression>NP_001411104.1:p.Cys616Phefs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1406" sequenceAccession="LRG_1406">
            <Expression>LRG_1406:g.147054del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1406t1" sequenceAccession="LRG_1406t1">
            <Expression>LRG_1406t1:c.1844del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1406p1" sequenceAccession="LRG_1406p1" change="p.Cys615fs">
            <Expression>LRG_1406p1:p.Cys615fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000044.6(AR):c.1844del (p.Cys615fs) AND multiple conditions" Accession="RCV003815492" Version="1">
        <ClassifiedConditionList TraitSetID="39851">
          <ClassifiedCondition DB="MedGen" ID="C0039585">Androgen resistance syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1839259">Kennedy disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19463997</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="39851" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4172" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1</ElementValue>
                <XRef Type="MIM" ID="313200" DB="OMIM" />
                <XRef Type="Allelic variant" ID="313700.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bulbo-spinal atrophy X-linked</ElementValue>
                <XRef ID="Kennedy+Disease/993" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Kennedy disease</ElementValue>
                <XRef ID="MONDO:0010735" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kennedy spinal and bulbar muscular atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spinal and bulbar muscular atrophy X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bulbospinal neuronopathy X-linked recessive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">KD</ElementValue>
                <XRef Type="MIM" ID="313200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SBMA</ElementValue>
                <XRef Type="MIM" ID="313200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SMAX1</ElementValue>
                <XRef Type="MIM" ID="313200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XBSN</ElementValue>
                <XRef Type="MIM" ID="313200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Spinal and bulbar muscular atrophy (SBMA) is a gradually progressive neuromuscular disorder in which degeneration of lower motor neurons results in muscle weakness, muscle atrophy, and fasciculations. SBMA occurs only in males. Affected individuals often show gynecomastia, testicular atrophy, and reduced fertility as a result of mild androgen insensitivity.</Attribute>
                <XRef ID="NBK1333" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6818" />
                <XRef ID="6818" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301508</ID>
                <ID Source="BookShelf">NBK1333</ID>
              </Citation>
              <XRef ID="481" DB="Orphanet" />
              <XRef ID="C1839259" DB="MedGen" />
              <XRef ID="MONDO:0010735" DB="MONDO" />
              <XRef Type="MIM" ID="313200" DB="OMIM" />
            </Trait>
            <Trait ID="303" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TESTICULAR FEMINIZATION SYNDROME</ElementValue>
                <XRef Type="MIM" ID="300068" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Androgen insensitivity syndrome</ElementValue>
                <XRef ID="MONDO:0019154" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Androgen receptor deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydrotestosterone receptor deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Androgen resistance syndrome</ElementValue>
                <XRef ID="Androgen+Insensitivity+Syndrome/435" DB="Genetic Alliance" />
                <XRef ID="12313004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Androgen insensitivity, complete</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Androgen insensitivity syndrome due to coactivator deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Androgen insensitivity</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AIS</ElementValue>
                <XRef Type="MIM" ID="300068" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TFM</ElementValue>
                <XRef Type="MIM" ID="300068" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Androgen insensitivity syndrome (AIS) is typically characterized by evidence of feminization (i.e., undermasculinization) of the external genitalia at birth, abnormal secondary sexual development in puberty, and infertility in individuals with a 46,XY karyotype. AIS represents a spectrum of defects in androgen action and can be subdivided into three broad phenotypes: Complete androgen insensitivity syndrome (CAIS), with typical female external genitalia. Partial androgen insensitivity syndrome (PAIS) with predominantly female, predominantly male, or ambiguous external genitalia. Mild androgen insensitivity syndrome (MAIS) with typical male external genitalia.</Attribute>
                <XRef ID="NBK1429" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000334288" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000266587" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508977" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512293" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520477" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000557906" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000240864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512294" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5803" />
                <XRef ID="5803" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301602</ID>
                <ID Source="BookShelf">NBK1429</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2008">
                <URL>http://www.eurogentest.org/web/files/public/unit3/ClinicalUtilityGeneCards/Indication%20criteria%20-%20CAIS.pdf</URL>
              </Citation>
              <XRef ID="754" DB="Orphanet" />
              <XRef ID="99429" DB="Orphanet" />
              <XRef ID="C0039585" DB="MedGen" />
              <XRef ID="MONDO:0019154" DB="MONDO" />
              <XRef Type="MIM" ID="300068" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8564134" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="28034616|MedGen:C1839259;C0039585" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004605989" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19463997</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Cys615Phefs*11) in the AR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AR are known to be pathogenic (PMID: 19463997). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with AR-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.66905927del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1839259" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039585" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8564134" TraitType="Disease" MappingType="XRef" MappingValue="C0039585" MappingRef="MedGen">
        <MedGen CUI="C0039585" Name="Androgen resistance syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8564134" TraitType="Disease" MappingType="XRef" MappingValue="C1839259" MappingRef="MedGen">
        <MedGen CUI="C1839259" Name="Kennedy disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

